Nils Lycke
Direktor/Vorstandsmitglied bei MIVAC Development AB
Profil
Nils Lycke is the founder of Toleranzia AB, which was founded in 2012.
He held the title of Director & Chief Scientific Officer from 2012 to 2018.
Dr. Lycke's current jobs include being a Director at MIVAC Development AB, a Director at Loni Medicals Aktiebolag, a Professor at the University of Gothenburg, and a Chief Physician at Sahlgrenska Universitetssjukhuset.
He previously worked as a Director at Gotimmune AB.
Aktive Positionen von Nils Lycke
| Unternehmen | Position | Beginn |
|---|---|---|
MIVAC Development AB
 MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Direktor/Vorstandsmitglied | - |
| University of Gothenburg | Corporate Officer/Principal | 02.06.2011 |
Sahlgrenska Universitetssjukhuset
 Sahlgrenska Universitetssjukhuset Hospital/Nursing ManagementHealth Services Sahlgrenska Universitetssjukhuset engages in the provision of basic and emergency medical care. It offers specialized care, pediatrics, transplant activity, treatment of cardiovascular diseases, immunology, and vaccine research. Its hospital provides an infrastructure necessary for teaching and research. The company was founded on January 1, 1997 and is based in Gothenburg, Sweden. | Corporate Officer/Principal | - |
| Loni Medicals Aktiebolag | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Nils Lycke
| Unternehmen | Position | Ende |
|---|---|---|
| TOLERANZIA AB | Gründer | 17.01.2018 |
Gotimmune AB
 Gotimmune AB Pharmaceuticals: MajorHealth Technology Gotimmune AB develops treatment for Helicobacter pylori. The company is headquartered in Goteborg, Sweden. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TOLERANZIA AB | Health Technology |
| Private Unternehmen | 4 |
|---|---|
MIVAC Development AB
MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Health Technology |
Sahlgrenska Universitetssjukhuset
Sahlgrenska Universitetssjukhuset Hospital/Nursing ManagementHealth Services Sahlgrenska Universitetssjukhuset engages in the provision of basic and emergency medical care. It offers specialized care, pediatrics, transplant activity, treatment of cardiovascular diseases, immunology, and vaccine research. Its hospital provides an infrastructure necessary for teaching and research. The company was founded on January 1, 1997 and is based in Gothenburg, Sweden. | Health Services |
Gotimmune AB
Gotimmune AB Pharmaceuticals: MajorHealth Technology Gotimmune AB develops treatment for Helicobacter pylori. The company is headquartered in Goteborg, Sweden. | Health Technology |
| Loni Medicals Aktiebolag |